Wichmann, G., et al.. Human Leukocyte Antigens and Haplotypes Allow for Prognostic Classification of HNSCC Patients. Proceedings on Cancer-Immuno-Oncology, Oct. 2018, doi:10.18416/cio.2018.1810001.